Schroderome Growth Fund (LSE:SCF) Research & Development: £0.00 Mil (TTM As of Feb. 2026)


LSE:SCF Schroder Income Growth Fund PLC LSE:SCF
29 GF Score
Price £3.58
! 5 Warning Signs
View Full Analysis

What is Schroderome Growth Fund Research & Development?

Schroderome Growth Fund LSE:SCF +0.28% 29 Research & Development is £0.00 Mil as of Feb. 2026. GuruFocus rates LSE:SCF with a GF Score™ of 29/100. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Schroderome Growth Fund's Research & Development for the six months ended in Feb. 2026 was £0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 was £0.00 Mil.

Schroderome Growth Fund  (LSE:SCF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Schroderome Growth Fund Research & Development Related Terms

Schroderome Growth Fund Research & Development Historical Data

* Premium members only.

The historical data trend for Schroderome Growth Fund's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Schroderome Growth Fund Research & Development Chart

Schroderome Growth Fund Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Schroderome Growth Fund Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:SCF
29GF Score
Schroder Income Growth Fund PLC LSE:SCF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Schroderome Growth Fund Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of £0.00 Mil mean?
Schroderome Growth Fund (LSE:SCF) has a Research & Development of £0.00 Mil as of Feb. 2026. Research and development expense is the total cost for research and development activities. View historical data on Schroderome Growth Fund and its competitors.
Is Schroderome Growth Fund's Research & Development too high?
Schroderome Growth Fund's current Research & Development is £0.00 Mil. Overall, Schroderome Growth Fund has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Schroderome Growth Fund's Research & Development compare to BLK and BX?
Schroderome Growth Fund's Research & Development of £0.00 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Asset Management company?
A good Research & Development depends on the Asset Management industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Schroderome Growth Fund and its competitors. Schroderome Growth Fund's current Research & Development is £0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Schroderome Growth Fund stock overvalued right now?
Schroderome Growth Fund (LSE:SCF) has a current Research & Development of £0.00 Mil. The current Research & Development is £0.00 Mil. Schroderome Growth Fund's overall GF Score™ is 29/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Schroderome Growth Fund (LSE:SCF), the current Research & Development is £0.00 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Schroderome Growth Fund Business Description

Address 1 London Wall Place, London, GBR, EC2Y 5AU
Schroder Income Growth Fund PLC is an investment trust engaged in the business of asset management. It manages assets of institutional and retail investors, financial institutions, and high net worth individuals. The company's objective is to provide growth of income by investing mainly in above average yielding UK equities, fixed income, multi-asset, alternatives and real estate asset classes. It invests across the markets with a focus on building a diversified portfolio within a risk-controlled framework and also consists of research, portfolio construction, and review/sell discipline stages.
29GF Score

Get the complete analysis for LSE:SCF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£3.58
Price